The Society of Professional Journalists, the nation’s oldest and one of its largest journalism associations, has canceled its 2024 national convention that was to be held in Indianapolis, citing a budget crisis and falling membership.... Read More
Indianapolis-based Corteva Agriscience is suing a Massachusetts startup, saying the company has taken Corteva’s patent-protected seeds, made slight genetic modifications, and is preparing to commercialize them under its own name.... Read More
Paul Halverson, the founding dean of the Indiana University Fairbanks School of Public Health and a longtime advocate for a stronger role for public health across the state, plans to step down in January after 10 years to take a position in Oregon.... Read More
The Indianapolis-based drugmaker said Monday it will build five large solar structures—three at the Lilly Corporate Center headquarters on the south edge of downtown and two at the sprawling Lilly Technology Center about two miles west.... Read More
A San Diego-based biotech firm that is building a plant in Indianapolis to manufacture radioisotopes for cancer treatment says it expects the facility to be completed by the end of the year, with production starting next year.... Read More
Indiana University Health’s sprawling, $4.3 billion downtown hospital project, which has been under construction for more than a year, will get another review from city officials this week due to a proposed change in some features.... Read More
The company, which is developing electrical-nerve stimulation therapies for children, went public this month at an initial price of $6 a share—lower than the range of $7 to $9 a share it announced in February.... Read More
Today, Lilly is on top of the world. The company has launched 20 drugs in the past decade to treat diseases from arthritis and psoriasis to diabetes and cancer.... Read More
It amounts to a major setback for Indiana, which is losing a top researcher in an exploding field of medicine, developing therapies for chronic wounds and other potentially life-threatening conditions that affect millions of people in the United States.... Read More
Carmel-based MBX Biosciences has received clearance from federal regulators to move its second experimental drug into human testing. The FDA gave the green light to test a drug for post-bariatric hypoglycemia, a serious complication of bariatric surgery.... Read More
